Neil Forbes, professor of chemical and biomolecular engineering, and Shradha Khanduja, doctoral candidate and first author, explain their research on using engineered non-toxic Salmonella bacteria to deliver viruses that are safe to humans but potent against liver and pancreatic cancer tumors, both with extremely poor prognosis.
3Daughters, a startup supported by the IALS Venture Development Program, announced closing of the first tranche in excess of $2 million in a Seed Round. This round was led by Thairm Bio, with a group of life science investors, and joined by the Argosy Foundation, Wexford Science and Technology, LLC, UMass Amherst, and other undisclosed investors.
Aclarity, a start-up supported by the IALS Venture Development program, successfully completed its Series A funding round, raising $15.9 million. Aclarity is a water technology company that quickly and safely destroys dangerous contaminants in water at the industrial scale and is the leader in PFAS (Per- and Polyfluoroalkyl Substances) "forever chemical" destruction.
Founders need to be able to tell their story in a minute. This workshop is your opportunity to come with a pitch to practice and improve on the spot. Space is limited and priority will be given to those applying to participate in the MALSI DAY 2024 Poster Pitch Showcase on July 25 (see below to apply). Those attending will get two rounds of feedback with a chance to improve their pitch in between rounds. Stephen Gordon, PhD and Peter Reinhart, founding director of IALS will be offering their feedback as serial entrepreneurs and technical founders.
Veterinary specialist Carlos Gradil has invented an intrauterine device, called the Pearl Pod, for horses who experience extreme symptoms during their heat cycle. This device is safer than oral hormone administration for human handlers or other devices that pose health risks to the horses.
Two startups supported by the IALS Venture Development program, Ernest Pharmaceuticals and Organicin Scientific, have been selected as finalists in the 2024 Lever Western Massachusetts Health Technology Challenge.
Ernest Pharmaceuticals, an IALS startup, team has demonstrated in theory that a protein antigen from a childhood vaccine can be delivered into the cells of a malignant tumor to refocus the body’s immune system against the cancer, effectively halting it and preventing its recurrence. The bacteria-based intracellular delivering (ID) system uses a non-toxic form of Salmonella that releases a drug, in this case a vaccine antigen, after it’s inside a solid-tumor cancer cell.
Come learn how the current investment climate is shaping decision-making across the sector, what early-stage research-driven startups can do to differentiate themselves, and how to approach both dilutive and non-dilutive capital options strategically.
IALS Collaboratories occupant florrent announced the successful close of their Pre-Seed fundraising round, which secured $2.1M of catalytic capital to bring their transformative energy storage solution to the world and realize the impact of their mission. These funds will enable florrent to begin outfitting their pilot manufacturing facility, where they will be scaling the production of their next-generation ultracapacitor activated carbon material, as well as invest in critical R&D equipment and build out their team of scientists, engineers, and professionals.
Lili He, professor and head of food science, and Yuzhen Zhang, a postdoctoral researcher, have created a smartphone-based technology to detect bacteria contamination on surfaces such as food processing plants, hospitals and other public environments.
Danielle O’Neal is SVP, Life Sciences for Banc of California where she leads the banks’ early-stage life sciences group. She is also a founder of Life Science Nation, a company that helps early-stage life science companies raise capital.
Since 2017, the Isenberg School of Management has partnered with IALS to enable on-campus MBA students to augment their business education with real-world experience by collaborating with faculty-founded technology startups. Nearly 90 on-campus MBA students have participated in this industry-like environment to build business plans to support more than 50 startups.
Peter Reinhart, Karen Utgoff, Julian Lustig-Gonzalez, Heather Aiken and Paul-Miki "Ralu" Ibekwe participated in a two and a half day course delivered at MIT.
Manning/IALS Innovation Program and U.S. NSF Accelerating Research Translation ProgramUMass Amherst invites submissions for the 2024 Translational Seed Awards of up to $100,000 for translational research and development to move UMass research towards impact through research-based startup ventures, out-licensing of patented or copyrighted work, scalable community engagement, social impact ventures, or other vehicles.
Manning/IALS Innovation Program and U.S. NSF Accelerating Research Translation Program
UMass Amherst invites submissions for the 2024 Translational Seed Awards of up to $100,000 for translational research and development to move UMass research towards impact through research-based startup ventures, out-licensing of patented or copyrighted work, scalable community engagement, social impact ventures, or other vehicles.
Manning/IALS Innovation Program and U.S. NSF Accelerating Research Translation Program
UMass Amherst invites submissions for the 2024 Translational Seed Awards of up to $100,000 for translational research and development to move UMass research towards impact through research-based startup ventures, out-licensing of patented or copyrighted work, scalable community engagement, social impact ventures, or other vehicles.
Manning/IALS Innovation Program and U.S. NSF Accelerating Research Translation Program
UMass Amherst invites submissions for the 2024 Translational Seed Awards of up to $100,000 for translational research and development to move UMass research towards impact through research-based startup ventures, out-licensing of patented or copyrighted work, scalable community engagement, social impact ventures, or other vehicles.
Have you ever wondered about the differences between trademarks, copyrights, patents, or how Creative Commons licenses work? Join us for an engaging virtual session exploring the fundamentals of intellectual property designed specifically for artists and creatives.
Not ready to meet but want to know more. Watch the video on What University Researchers Should Know About Intellectual Property.
Join us for an info session over lunch with Spencer Babcock, Activate Boston, and Jose LaSalle, florrent CEO and 2023 Activate Fellow!
Register for the info session. 1:1 meetings available by request.
UMass Amherst invites submissions for the 2024 Translational Seed Awards of up to $100,000 for translational research and development to move UMass research towards impact through research-based startup ventures, out-licensing of patented or copyrighted work, scalable community engagement, social impact ventures, or other vehicles.
Congratulations to the nine UMass Amherst founders who participated in the Massachusetts Life Science and Innovation Day at The Engine at MIT.
Myrias Optics, built on research developed by the Watkins Group at UMass Amherst, announced that it has secured a $3 million seed investment led by Asia Optical Inc. Myrias, an emerging developer of all-inorganic printed meta-optics, will use the funding to meet growing customer demand and interest in the company’s structure, materials and process technology platform.
Griffin Kane, co-founder and CEO, receives Judges’ Choice Best Startup at the 19th annual Massachusetts Life Sciences Innovation (MALSI) Day, on July 23rd, earning top honors among emerging life sciences ventures from across Massachusetts.
A team from the University of Massachusetts Amherst’s Institute for Applied Life Sciences (IALS), Technology Transfer Office, Office of Research & Engagement and the Office of the Provost has won a $5.5 million Accelerating Research Translation (ART) award from the U.S. National Science Foundation (NSF) to support and expand faculty and student researchers’ efforts to translate research conducted in campus laboratories into tangible solutions to real-world problems.
Optical Waters, a startup supported by the IALS Venture Development program, was awarded National Science Foundation Small Business Innovation Research Phase II (NSF SBIR Phase II) funding in order to scale and optimize their manufacturing methods.
A startup involving UMass faculty and students can be an impactful way to translate UMass research and inventions into solutions that address unmet needs in the real world. This panel discussion will demystify key campus organizations and policies for UMass researchers aiming to establish new for-profit or non-profit ventures.
Email your preferred time to [email protected] and copy [email protected] to arrange a virtual meeting.
Email your preferred time to [email protected] and copy [email protected] to arrange a virtual meeting.
Email your preferred time to [email protected] and copy [email protected] to arrange a virtual meeting.
Email your preferred time to [email protected] and copy [email protected] to arrange a virtual meeting.
Email your preferred time to [email protected] and copy [email protected] to arrange a virtual meeting.
When bridging from research and impactful research-based solutions to unmet needs and unsolved problems in the real world, it is critical to build support for a project with potential stakeholders, team members, and funders. A presentation that pitches the project to such groups is often a key tool.
Ernest Pharmaceuticals and Organicin Scientific have won the top prizes at Lever’s 2024 Western Massachusetts Health Tech Challenge
The UMass Innovation Institute (UMII) is excited to share a workshop for faculty and the UMass community in conjunction with HALO Science to share their platform for identifying new industry projects. If you are interested in finding partners aligned to your research interests, or funding for your startup, this workshop will give you the opportunity to get an overview of the platform and projects.
Hosted by UMII and Halo Science.
